Fig. 2.

Change from baseline in body weight at week 26. a History of CV disease, b history of hypertension, c baseline statin use, d number of CV risk factors. CV cardiovascular, LS least squares, SE standard error, CI confidence interval, PBO placebo, CANA canagliflozin